← Back to Seller Analysis

NOVARTIS PHARMACEUTICALS UK LIMITED

Seller Intelligence Snapshot

Coverage Range
2025-05-14 10:42 UTC to 2026-01-12 09:49 UTC.
Last Refresh
2026-03-18 08:12 UTC
Coverage Toggle
Find a Tender (30)
Sources
Awards
30
Open Notices
0
Known GBP Value
£1,058,731,006
Avg Award Value (Known GBP)
£35,291,034
Active Sectors
2
Awarding Buyers
5

Concentration

What this meansValue
Dependence on biggest customer 36.7% (Medium dependence)
Dependence on biggest sector 90.0% (High dependence)
Customer concentration score 2711.1 (High concentration)
Sector concentration score 8200.0 (High concentration)

Interpretation: a higher concentration score means awards are concentrated in fewer buyers or sectors.

Award Notices

Page 1 of 2 (30 total)

TitleStatusBuyerValueSectorSourcePublished
Generic, Branded Generic & Proprietary Medicinal Products - Group 17 complete Regional Business Services Organisation, Procurement and Logistics Service £415,333 Pharmaceutical products Find a Tender 12 Jan 2026, 09:49 View notice
NHS National Framework Agreement for Omalizumab complete NHS England £87,433,000 Pharmaceutical products Find a Tender 30 Dec 2025, 16:29 View notice
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection complete Western Health & Social Care Trust £4,638,166 Pharmaceutical products Find a Tender 08 Dec 2025, 12:50 View notice
PRRT (Peptide Receptor Radionuclide Therapy) complete Belfast Health & Social Care Trust £1,820,000 Medical equipments, pharmaceuticals and personal care products Find a Tender 02 Dec 2025, 08:28 View notice
NHS National Framework Agreement for Omalizumab complete NHS England £87,433,000 Pharmaceutical products Find a Tender 28 Nov 2025, 12:23 View notice
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection complete Western Health & Social Care Trust £4,638,166 Pharmaceutical products Find a Tender 10 Nov 2025, 16:36 View notice
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection complete Western Health & Social Care Trust £4,638,166 Pharmaceutical products Find a Tender 10 Nov 2025, 15:58 View notice
PRRT (Peptide Receptor Radionuclide Therapy) complete Belfast Health & Social Care Trust £1,820,000 Medical equipments, pharmaceuticals and personal care products Find a Tender 10 Nov 2025, 12:02 View notice
PRRT (Peptide Receptor Radionuclide Therapy) complete Belfast Health & Social Care Trust £1,820,000 Medical equipments, pharmaceuticals and personal care products Find a Tender 10 Nov 2025, 11:56 View notice
NHS National Framework for Transition products (Axitinib and Eltrombopag) complete NHS England £52,385,000 Pharmaceutical products Find a Tender 04 Sep 2025, 16:47 View notice
MIDOSTAURIN 25MG CAPSULES complete Northern Health And Social Care Trust £180,000 Pharmaceutical products Find a Tender 03 Sep 2025, 13:34 View notice
Canakinumab complete Northern Health And Social Care Trust £120,000 Pharmaceutical products Find a Tender 03 Sep 2025, 09:22 View notice
NHS National Framework for Transition products (Nilotinib and Ticagrelor) complete NHS England £22,097,000 Pharmaceutical products Find a Tender 20 Aug 2025, 07:17 View notice
ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL complete Northern Health And Social Care Trust £700,000 Pharmaceutical products Find a Tender 14 Aug 2025, 10:52 View notice
MIDOSTAURIN 25MG CAPSULES complete Northern Health And Social Care Trust £180,000 Pharmaceutical products Find a Tender 13 Aug 2025, 15:27 View notice
MIDOSTAURIN 25MG CAPSULES complete Northern Health And Social Care Trust £180,000 Pharmaceutical products Find a Tender 13 Aug 2025, 15:16 View notice
Canakinumab complete Northern Health And Social Care Trust £120,000 Pharmaceutical products Find a Tender 07 Aug 2025, 14:26 View notice
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 complete NHS ENGLAND £688,834,174 Pharmaceutical products Find a Tender 01 Aug 2025, 10:49 View notice
NHS National Framework for Transition products (Axitinib and Eltrombopag) complete NHS England £52,385,000 Pharmaceutical products Find a Tender 30 Jul 2025, 10:23 View notice
NHS National Framework for Transition products (Nilotinib and Ticagrelor) complete NHS ENGLAND £22,097,000 Pharmaceutical products Find a Tender 11 Jul 2025, 12:24 View notice
Previous Next

Top Buyers (Awarding)

Page 1 of 1 (6 buyers)

BuyerAward CountKnown GBPMost Recent AwardSector ConcentrationOpportunities
Belfast Health & Social Care Trust 11 £8,040,000 02 Dec 2025, 08:28 Pharmaceutical products View notices
Northern Health And Social Care Trust 7 £1,600,000 03 Sep 2025, 13:34 Pharmaceutical products View notices
NHS England 5 £301,733,000 30 Dec 2025, 16:29 Pharmaceutical products View notices
NHS ENGLAND 3 £733,028,174 01 Aug 2025, 10:49 Pharmaceutical products View notices
Western Health & Social Care Trust 3 £13,914,499 08 Dec 2025, 12:50 Pharmaceutical products View notices
Regional Business Services Organisation, Procurement and Logistics Service 1 £415,333 12 Jan 2026, 09:49 Pharmaceutical products View notices
Previous Next

Top Overlapping Competitors

Loading competitor overlaps...

Top Sectors by Notice Count

SectorNoticesOpportunities
Pharmaceutical products27View notices
Medical equipments, pharmaceuticals and personal care products3View notices

Top Sectors by Known GBP Value

SectorKnown GBPNoticesOpportunities
Pharmaceutical products£1,053,271,00627View notices
Medical equipments, pharmaceuticals and personal care products£5,460,0003View notices

Top CPV Codes

CPV CodeDescriptionNoticesKnown GBPOpportunities
33600000Pharmaceutical products27£1,053,271,006View notices
33000000Medical equipments, pharmaceuticals and personal care products3£5,460,000View notices

Monthly Trend

MonthTotalOpenAwardedKnown GBP
May 2025404£1,320,000
Jun 2025505£1,380,000
Jul 2025303£96,579,000
Aug 2025606£712,111,174
Sep 2025303£52,685,000
Nov 2025505£100,349,333
Dec 2025303£93,891,166
Jan 2026101£415,333

Months active in last 12: 8. Longest active streak: 5 months.

Data Quality

Known GBP coverage: 100.0% of notices have known GBP values.

Buyer attribution coverage: 100.0% of notices have buyer names populated.